Personalised Nutritional Recommendations Based on Individual Post-Prandial Glycaemic Responses Improve Glycaemic Metrics and PROMs in Patients with Type 2 Diabetes: A Real-World Assessment.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
19 May 2022
Historique:
received: 20 04 2022
revised: 11 05 2022
accepted: 16 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

The recommended first-line therapy in type 2 diabetes (T2D) is lifestyle modification. In many patients, such interventions fail, and disease progresses inexorably to medication requirement. A potential reason for the failure of standard nutritional interventions is the use of generic dietary advice, with no personalisation to account for differences in the effect of food on blood glucose between different individuals. Another is the lack of instant feedback on the impact of dietary modification on glycaemic control, which supports sustained behaviour change. The use of continuous glucose monitoring (CGM) may help address both these shortcomings. We conducted an observational study to explore how personalised nutritional information impacts glycaemic control and patient-reported outcome measures (PROMs) of well-being. Free-living people with T2D eating their normal diet were provided with personalised nutritional recommendations by state-registered nutritionists based on the CGM-enabled analysis of individual post-prandial glycaemic responses (PPGRs). Participants demonstrated considerable inter-individual differences in PPGRs, reductions in post-prandial incremental area under the curve (iAUC) and daytime AUC, and improvements in energy levels, ability to concentrate, and other PROMs. These results suggest a role for personalised nutritional recommendations based on individual-level understanding of PPGRs in the non-pharmaceutical management of T2D.

Identifiants

pubmed: 35631264
pii: nu14102123
doi: 10.3390/nu14102123
pmc: PMC9145975
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Una Health GmBh
ID : N/A

Références

Diabetes Res Clin Pract. 2021 Apr;174:108738
pubmed: 33711395
Digit Health. 2020 Jan 8;6:2055207619898984
pubmed: 31949918
J Diabetes Sci Technol. 2022 Mar;16(2):578-580
pubmed: 34696604
J Endocr Soc. 2020 Aug 18;4(11):bvaa118
pubmed: 33094208
Diabetes Metab Res Rev. 2013 Aug 24;:
pubmed: 23983176
Diabetes Care. 2014 Oct;37(10):2738-45
pubmed: 25024396
Diabetes Care. 2005 Mar;28(3):626-31
pubmed: 15735199
Exp Biol Med (Maywood). 2016 Sep;241(15):1724-31
pubmed: 27390262
Cell Metab. 2022 Jan 4;34(1):11-20
pubmed: 34986330
BMJ Open. 2019 Jan 17;9(1):e024008
pubmed: 30782722
BMC Public Health. 2018 Jan 31;18(1):204
pubmed: 29386030
Diabetes Care. 2012 Jan;35(1):32-8
pubmed: 22100963
Diabetologia. 2022 Jan;65(1):3-13
pubmed: 34837505
Am J Lifestyle Med. 2019 Mar 20;14(2):169-186
pubmed: 32231483
Int J Psychiatry Med. 2002;32(3):235-47
pubmed: 12489699
Diabetes Spectr. 2017 Feb;30(1):43-50
pubmed: 28270714
Diabetes Res Clin Pract. 2017 Sep;131:70-81
pubmed: 28692830
Food Nutr Bull. 2020 Dec;41(2_suppl):59S-73S
pubmed: 33356592
Lancet. 2009 Nov 14;374(9702):1677-86
pubmed: 19878986
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
Diabetes Ther. 2019 Apr;10(2):509-522
pubmed: 30706365
Diabetes. 2017 Jun;66(6):1432-1442
pubmed: 28533294
Sci Rep. 2018 Nov 16;8(1):16938
pubmed: 30446674
J Pers Med. 2021 Aug 14;11(8):
pubmed: 34442439
J Diabetes Sci Technol. 2019 Mar;13(2):271-275
pubmed: 30066574
Stud Health Technol Inform. 2020 Jun 16;270:951-955
pubmed: 32570522
Appetite. 2017 May 1;112:249-259
pubmed: 28153701
Cell. 2015 Nov 19;163(5):1079-1094
pubmed: 26590418
Biomark Insights. 2016 Jul 03;11:95-104
pubmed: 27398023
Nat Med. 2020 Jun;26(6):964-973
pubmed: 32528151
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
J Diabetes Investig. 2018 Jul;9(4):713-725
pubmed: 29380542
Appetite. 2016 Apr 1;99:168-176
pubmed: 26796421
Eur J Nutr. 2021 Feb;60(1):259-273
pubmed: 32277270

Auteurs

Madlen Ungersboeck (M)

Una Health GmbH, Rosenthaler Str. 13, 10119 Berlin, Germany.

Xiaowen Tang (X)

Una Health GmbH, Rosenthaler Str. 13, 10119 Berlin, Germany.

Vanessa Neeff (V)

Una Health GmbH, Rosenthaler Str. 13, 10119 Berlin, Germany.

Dominic Steele (D)

Una Health GmbH, Rosenthaler Str. 13, 10119 Berlin, Germany.

Pascal Grimm (P)

Una Health GmbH, Rosenthaler Str. 13, 10119 Berlin, Germany.

Matthew Fenech (M)

Una Health GmbH, Rosenthaler Str. 13, 10119 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH